Brad Edgar Joins Stifel as Managing Director and Lead Healthcare Equity Trader
Stifel Financial Corp. (NYSE: SF) has appointed Brad Edgar as Managing Director and Lead Healthcare Equity Trader in their New York office. Edgar, who joins from Seven Grand Managers where he was Partner, brings over 20 years of healthcare equity trading experience from positions at BMO, Evercore, and UBS. The appointment strengthens Stifel's healthcare vertical, where the company maintains a significant presence with specialist sales force, investment banking, and equity research capabilities. Stifel currently ranks among the largest traders of public healthcare companies, making markets in more than 700 healthcare stocks.
Stifel Financial Corp. (NYSE: SF) ha nominato Brad Edgar come Direttore Generale e Responsabile del Trading di Azioni Sanitarie nel loro ufficio di New York. Edgar, che proviene da Seven Grand Managers dove era Partner, porta con sé oltre 20 anni di esperienza nel trading di azioni sanitarie, avendo ricoperto ruoli presso BMO, Evercore e UBS. La nomina rafforza il settore sanitario di Stifel, dove l'azienda mantiene una presenza significativa con una forza vendita specializzata, investimenti bancari e capacità di ricerca sulle azioni. Stifel attualmente si classifica tra i maggiori trader di aziende sanitarie pubbliche, operando in più di 700 azioni sanitarie.
Stifel Financial Corp. (NYSE: SF) ha nombrado a Brad Edgar como Director General y Líder de Trading de Acciones de Salud en su oficina de Nueva York. Edgar, que se une desde Seven Grand Managers donde era Socio, aporta más de 20 años de experiencia en el trading de acciones de salud, habiendo ocupado posiciones en BMO, Evercore y UBS. Esta designación fortalece el sector de salud de Stifel, donde la compañía mantiene una presencia significativa con una fuerza de ventas especializada, banca de inversión y capacidades de investigación de acciones. Stifel actualmente se encuentra entre los mayores traders de empresas de salud pública, operando en más de 700 acciones de salud.
Stifel Financial Corp. (NYSE: SF)는 뉴욕 사무소에서 전무이사 및 헬스케어 주식 거래 책임자로 브래드 에드거를 임명했습니다. 에드거는 파트너로 있었던 세븐 그랜드 매니저스에서 합류하며, BMO, Evercore 및 UBS에서의 20년 이상의 헬스케어 주식 거래 경험을 가지고 있습니다. 이번 임명은 Stifel의 헬스케어 부문을 강화시키며, 회사는 전문 영업팀, 투자은행 및 주식 연구 능력을 갖추고 있는 중요한 존재입니다. Stifel은 현재 공개 헬스케어 기업의 주요 거래자 중 하나로, 700개 이상의 헬스케어 주식에서 거래하고 있습니다.
Stifel Financial Corp. (NYSE: SF) a nommé Brad Edgar en tant que Directeur Général et Responsable du Trading d'Actions de Santé dans son bureau de New York. Edgar, qui rejoint Seven Grand Managers où il était Associé, apporte plus de 20 ans d'expérience dans le trading d'actions de santé, ayant occupé des postes chez BMO, Evercore et UBS. Cette nomination renforce le secteur de la santé de Stifel, où la société possède une présence significative avec une force de vente spécialisée, de la banque d'investissement et des capacités de recherche en actions. Stifel figure actuellement parmi les plus grands traders d'entreprises de santé publiques, opérant sur plus de 700 actions de santé.
Stifel Financial Corp. (NYSE: SF) hat Brad Edgar zum Geschäftsführer und leitenden Gesundheitsaktienhändler in ihrem Büro in New York ernannt. Edgar, der von Seven Grand Managers kommt, wo er Partner war, bringt über 20 Jahre Erfahrung im Handel mit Gesundheitsaktien aus Positionen bei BMO, Evercore und UBS mit. Die Ernennung stärkt die Gesundheitsabteilung von Stifel, wo das Unternehmen eine bedeutende Präsenz mit einem spezialisierten Verkaufsteam, Investment Banking und Aktienforschungskompetenzen hat. Stifel gehört derzeit zu den größten Händlern öffentlicher Gesundheitsunternehmen und tätigt Geschäfte in mehr als 700 Gesundheitsaktien.
- Strategic hire strengthens healthcare trading division with 20+ years industry expertise
- Company maintains strong market-making position in 700+ healthcare stocks
- Established healthcare presence with dedicated sales, banking, and research capabilities
- None.
ST. LOUIS, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced the hiring of Brad Edgar as Managing Director and Lead Healthcare Equity Trader. He is based in the firm’s New York office and reports directly to R.J. Grant, Head of Global Equity Trading at Stifel.
Mr. Edgar joins Stifel from Seven Grand Managers, where he served as Partner, responsible for all risk execution and trading of the firm’s equity portfolio. He brings more than 20 years of healthcare equity trading experience to his new role, having held the position of Head of Healthcare Equity Trading at firms including BMO, Evercore, and UBS. He began his career in healthcare equity trading at Merrill Lynch.
“Brad brings over two decades of experience, successfully leading trading teams and cultivating strong relationships across the healthcare investment community, and we’re thrilled to welcome him to the team,” said R.J. Grant. “Healthcare is one of our most important verticals and this appointment underscores our commitment to attract outstanding talent and offer best in class execution services.”
Mr. Edgar added, “I am pleased to join Stifel, which continues to set the standard for premier client service and has significant momentum across the sector. I look forward to leveraging my industry experience and customer-centric approach to help drive best execution and extend our leadership position in healthcare.”
Stifel’s presence in the healthcare sector includes a dedicated specialist sales force, investment banking and equity research across all verticals of healthcare, and a flagship annual Healthcare Conference, which attracts 1,000 industry participants. Market making in more than 700 stocks across the healthcare spectrum, Stifel ranks among the largest traders of public healthcare companies.
Stifel Company Information
Stifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners business division; Keefe, Bruyette & Woods, Inc.; Miller Buckfire & Co., LLC; and Stifel Independent Advisors, LLC. The Company’s broker-dealer affiliates provide securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, professional money managers, businesses, and municipalities. Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A. offer trust and related services. To learn more about Stifel, please visit the Company’s website at www.stifel.com. For global disclosures, please visit https://www.stifel.com/investor-relations/press-releases.
Media Contact:
Neil Shapiro, +1 (212) 271-3447
shapiron@stifel.com
Alex Hamer, +1 (212) 847-6673
hameral@stifel.com
FAQ
Who is the new Lead Healthcare Equity Trader at Stifel (NYSE: SF)?
How many healthcare stocks does Stifel (NYSE: SF) make markets in?
What was Brad Edgar's previous position before joining Stifel (NYSE: SF)?
What is Stifel's (NYSE: SF) current position in healthcare trading?
